These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


177 related items for PubMed ID: 10965635

  • 1. Effectiveness of exposure and ritual prevention for obsessive-compulsive disorder: randomized compared with nonrandomized samples.
    Franklin ME, Abramowitz JS, Kozak MJ, Levitt JT, Foa EB.
    J Consult Clin Psychol; 2000 Aug; 68(4):594-602. PubMed ID: 10965635
    [Abstract] [Full Text] [Related]

  • 2. D-cycloserine does not enhance exposure-response prevention therapy in obsessive-compulsive disorder.
    Storch EA, Merlo LJ, Bengtson M, Murphy TK, Lewis MH, Yang MC, Jacob ML, Larson M, Hirsh A, Fernandez M, Geffken GR, Goodman WK.
    Int Clin Psychopharmacol; 2007 Jul; 22(4):230-7. PubMed ID: 17519647
    [Abstract] [Full Text] [Related]

  • 3. How effective are cognitive and behavioral treatments for obsessive-compulsive disorder? A clinical significance analysis.
    Fisher PL, Wells A.
    Behav Res Ther; 2005 Dec; 43(12):1543-58. PubMed ID: 16239151
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Obsessive-compulsive hoarding: symptom severity and response to multimodal treatment.
    Saxena S, Maidment KM, Vapnik T, Golden G, Rishwain T, Rosen RM, Tarlow G, Bystritsky A.
    J Clin Psychiatry; 2002 Jan; 63(1):21-7. PubMed ID: 11838621
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Intensive outpatient treatment for obsessive-compulsive spectrum disorders.
    Ben-Arush O, Wexler JB, Zohar J.
    Isr J Psychiatry Relat Sci; 2008 Jan; 45(3):193-200. PubMed ID: 19398823
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Need for speed: evaluating slopes of OCD recovery in behavior therapy enhanced with d-cycloserine.
    Chasson GS, Buhlmann U, Tolin DF, Rao SR, Reese HE, Rowley T, Welsh KS, Wilhelm S.
    Behav Res Ther; 2010 Jul; 48(7):675-9. PubMed ID: 20362975
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Thematic similarity and clinical outcome in obsessive-compulsive disorder group treatment.
    Norton PJ, Whittal ML.
    Depress Anxiety; 2004 Jul; 20(4):195-7. PubMed ID: 15580573
    [Abstract] [Full Text] [Related]

  • 17. [Value of fluoxetine in obsessive-compulsive disorder in the adult: review of the literature].
    Etain B, Bonnet-Perrin E.
    Encephale; 2001 Jul; 27(3):280-9. PubMed ID: 11488259
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Drug treatment of obsessive-compulsive disorder. With proper drugs and some patience many patients can be helped].
    Mavrogiorgou P, Hegerl U.
    MMW Fortschr Med; 1999 Sep 30; 141(39):32-4, 37. PubMed ID: 10897982
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.